Literature DB >> 30406933

Laparoscopic resection of splenic flexure colon cancers: a retrospective multi-center study with 117 cases.

Michele Grieco1, Diletta Cassini2, Domenico Spoletini3, Enrica Soligo4, Emanuela Grattarola5, Gianandrea Baldazzi2, Silvio Testa4, Massimo Carlini3.   

Abstract

The objective is to investigate the short- and long-term outcomes of laparoscopic resections of splenic flexure colon cancers in three Italian high-volume centers. The laparoscopic resection of splenic flexure colon cancers is a challenging procedure and has not been completely standardized, mainly due to the technical difficulty, the arduous identification of major blood vessels, and the problems associated with anastomosis construction. In this retrospective cohort observational study, a consecutive series of patients treated in three Italian high-volume centers with elective laparoscopic resection of the splenic flexure for cancer is analyzed. The observational period was from January 2008 to August 2017. Patient demographics and clinical features, operative data, and short- and long-term outcomes were prospectively recorded in a specific database and were retrospectively analyzed. During the observation period, 117 patients were selected. Conversion to open surgery was necessary in 15 patients (12.8%). Of 102 complete laparoscopic procedures, multi-visceral resection was performed in 13 cases (12.7%). Postoperative surgical complications occurred in 13 patients (12.7%), with 3 cases of anastomotic leak (2.9%) and 3 cases of re-operation (2.9%). The postoperative mortality in this population was null. The 5-year overall survival rate was 84.3%, and the 5-year disease-free survival rate was 87.8%. Laparoscopic resection of the splenic flexure is feasible and safe in high-volume centers. Compared to the results of other laparoscopic colonic resections, the short- and long-term outcomes are similar, but the conversion rate is higher.

Entities:  

Keywords:  Colon cancer; Laparoscopic resection; Splenic flexure

Mesh:

Year:  2018        PMID: 30406933     DOI: 10.1007/s13304-018-0601-x

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  5 in total

1.  Extended right colectomy, left colectomy, or segmental left colectomy for splenic flexure carcinomas: a European multicenter propensity score matching analysis.

Authors:  Nicola de'Angelis; Aleix Martínez-Pérez; Des C Winter; Filippo Landi; Giulio Cesare Vitali; Bertrand Le Roy; Federico Coccolini; Francesco Brunetti; Valerio Celentano; Salomone Di Saverio; Frederic Ris; David Fuks; Eloy Espin
Journal:  Surg Endosc       Date:  2020-02-18       Impact factor: 4.584

2.  Laparoscopic right colectomy: changes in surgical technique and perioperative management allow better postoperative results in a comparative series of 361 patients.

Authors:  Michele Grieco; Rosa Marcellinaro; Domenico Spoletini; Rosa Menditto; Giorgio Lisi; Giulia Russo; Vincenzo Napoleone; Massimo Carlini
Journal:  Updates Surg       Date:  2022-04-12

3.  Implementation of the gut microbiota prevents anastomotic leaks in laparoscopic colorectal surgery for cancer:the results of the MIRACLe study.

Authors:  Massimo Carlini; Michele Grieco; Domenico Spoletini; Rosa Menditto; Vincenzo Napoleone; Gioia Brachini; Andrea Mingoli; Rosa Marcellinaro
Journal:  Updates Surg       Date:  2022-06-23

4.  Laparoscopic versus open surgery for left flexure colon cancer: A propensity score matched analysis from an international cohort.

Authors:  Corrado Pedrazzani; Giulia Turri; Soo Yeun Park; Koya Hida; Yudai Fukui; Jacopo Crippa; Giovanni Ferrari; Matteo Origi; Gaya Spolverato; Matteo Zuin; Sung Uk Bae; Seong Kyu Baek; Andrea Costanzi; Dario Maggioni; Gyung Mo Son; Andrea Scala; Timothy Rockall; David W Larson; Alfredo Guglielmi; Gyu Seog Choi
Journal:  Colorectal Dis       Date:  2021-11-09       Impact factor: 3.917

5.  Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the "Lazio Network" Database.

Authors:  Michele Grieco; Giampaolo Galiffa; Rosa Marcellinaro; Emanuele Santoro; Roberto Persiani; Stefano Mancini; Massimiliano Di Paola; Roberto Santoro; Francesco Stipa; Antonio Crucitti; Massimo Carlini
Journal:  World J Surg       Date:  2022-08-16       Impact factor: 3.282

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.